NDCFind

Crenessity 70370-5100

Generic: Crinecerfont

Product NDC

70370-5100
Manufacturer
Neurocrine Biosciences, Inc.
Dosage Form
Capsule
Route
Oral
Product Type
Human Prescription Drug
Marketing Start
December 13, 2024
Listing Expires
December 31, 2026
Application
NDA218808
StockMeds — pharmacy-to-pharmacy marketplace

Need to source Crenessity? P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

IngredientStrength
Crinecerfont100 mg/1

Drug Class

Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]

Packaging Options(1)

30 CAPSULE in 1 BOTTLE (70370-5100-1)